alexa Bipradeb Singha | The Wistar Institute of Anatomy and B
ISSN: 2157-7013

Journal of Cell Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Bipradeb Singha

Bipradeb Singha Bipradeb Singha
Professor
The Wistar Institute of Anatomy and Biology
Philadelphia, USA
Biography

Bipradeb Singha Currently I am working as a Post-Doctoral Fellow at the Cancer Center of The Wistar Institute of Anatomy and Biology, Philadelphia.  In 2015, I got my PhD in Biological Sciences from St. John’s University, NY where I have analyzed the mechanisms of transcriptional regulation of pro-inflammatory chemokines in ovarian cancer and determined an effective combination therapy for the treatment of chemotherapy resistant ovarian cancer. Prior to that, I completed my M.S and M.Phil in biology from St. John’s University in 2013 and 2014 respectively. Before I came to the US in 2010 to pursue my graduate studies in biology, I completed my Bachelors in Pharmacy, from West Bengal University of Technology, India. To this date, I have authored 6 papers in different peer reviewed journals along with several national and international posters at several scientific conferences. I have also received the highly competitive doctoral/post doctoral travel award grant from ASBMB (American Society for Biochemistry and Molecular Biology) in 2014. Currently I am a member of AAAS (American Association for the Advancement of Sciences).

Research Interest

My research focuses towards the determination of a clinically relevant panel of biomarkers for early detection of ovarian cancer using proteomics and understanding the mechanisms of drug resistance among the different subtypes of ovarian cancer.

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords